Drug intelligence / Profile preview

Repavar Atopic Piel

Development stage
Unknown
Lead developer
Ferrer
Administration
Topical
01

Overview

**Repavar Atopic Piel** is a line of emollient skincare products formulated for atopic skin, particularly during flare-ups and for daily maintenance. It contains **Skincalm Complex**, a blend of active ingredients including linoleic acid, hydrolyzed vegetable protein, biomimetic lipid complex (ceramides NP, AP, EOP, cholesterol, phytosphingosine), seven plant extracts (Centella asiatica, Polygonum cuspidatum, Scutellaria baicalensis, Camellia sinensis, Chamomilla recutita, Glycyrrhiza glabra, Rosmarinus officinalis, Peumus boldus), dihidroavenantramida D, and boldo extract, which provide antihistaminic, anti-irritant, anti-inflammatory, antipruritic, and antioxidant effects. The products restore the skin's hydrolipidic barrier, reduce transepidermal water loss, promote epidermal protein synthesis, offer antimicrobial protection, and alleviate itching, redness, and extreme dryness more effectively than corticosteroids in vitro for preventing pro-inflammatory molecule release. Dermatologically and pediatrically tested, hypoallergenic, suitable for sensitive skin and children over 1 month, available as cream (extreme and facial), lotion, bath gel, shampoo, and oleoducha.[1][2][4][7]

Brand names
Repavar Atopic Piel

Beyond the preview

Go deeper on Repavar Atopic Piel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Repavar Atopic Piel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call